Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
The Hybrid Approach in CAD with Restore® DEB
Author(s): Alfonso Ielasi Added: 11 months ago
In this comprehensive video series, Dr Alfonso Ielasi (IRCCS Ospedale Galeazzi Sant'Ambrogio, IT) delves into the approach of using Restore® Drug-Eluting Balloon (DEB) in treating Coronary Artery Disease (CAD). View more

Intervention
Women's Cardiovascular Health: Addressing Sex Differences, Cardio-Obstetrics & the Heart Team Approach
Author(s): Mirvat Alasnag , Julia Grapsa , Ahmed Krimly Added: 10 months ago
Join this insightful discussion on women's cardiovascular health!ICR3 Guest Editor, Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), leads a conversation with Drs Julia Grapsa (Guy's and St Thomas' NHS Foundation Trust, UK) and Ahmed Krimly (King Faisal Cardiac Center, SA), authors of a special focus issue on this critical topic.Key themes explored:Disparities in heart failure care for… View more

Demographic

Imaging & Diagnostics
Approaches to Bifurcation Management
Author(s): Sean Gallagher , Tom Johnson , Elliot Smith , et al Added: 1 year ago
Watch this five part series for a didactic blend of research and practice, centred around a practical case from the University Hospital of Wales with operatorsDr Sean Gallagher,Dr Tom JohnsonandDr Elliot Smith. They discuss the importance of pre-procedural planning, coronary physiology and imaging whilst treating complex anatomies. In addition,Dr Evald Christiansen(Aarhus University Hospital,… View more

Intervention
Evidence-Based Approaches to Optimising Treatment Outcome
Author(s): Javed Butler , Shelley Zieroth , Gianluigi Savarese Added: 8 months ago
Radcliffe Medical Education, is proud to bring to you this roundtable series which is designed to equip healthcare professionals with the knowledge and tools necessary to identify high-risk patients indicative of worsening HF and to implement effective management strategies. Watch Dr Javed Butler (Baylor Scott & White Health, Dallas, US); Dr Shelley Zieroth (University of Manitoba, Winnipeg, CA)… View more

Heart Failure
Coronary Physiology and DCBs: The Modern Approach for CTO-PCI
Author(s): Roberto Garbo , , , et al Start date: Jun 03, 2024
Join us for a transformative broadcast, chaired by Dr Tomáš Kovárník (Charles University, Prague, CZ), showcasing the latest advancements in CTO PCI procedures with state-of-the-art technology.Investigate the possibility of shortening stent lengths with precision physiology guidance, featuring Dr Mohamed Ayoub's (University Heart Center NRW, Bad Oeynhausen, DE) presentationExplore the combination… View more

Imaging & Diagnostics

Intervention
Treatment Options and Continuity of Care in MAFLD
Author(s): Carmen Lara-Romero , Manuel Romero-Gómez Added: 11 months ago

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Job title: Specialist in cardiac surgery
Specialist in cardiac surgery since 2014, Dr Maurizio Taramasso has completed his surgical training at the San Raffaele University Hospital in Milan, Italy. He has also done specific cross-training in interventional cardiology and heart valve transcatheter therapies (mitral and aortic) at the San Raffaele University Hospital. His main areas of interest include surgical and catheter treatments of… View more
ACC 25: The MIGHTy-Heart Trial
Author(s): Ruth Masterson Creber Added: 1 month ago
ACC 25 - Findings of the MIGHTy-Heart study shows no difference between mobile integrated healthcare and a traditional transitions of care coordinator approach in 30-day all-cause readmissions or health status.Dr Ruth Masterson Creber (Columbia University, New York, US) joins us onsite at ACC to discuss the findings from MIGHTy-Heart, a comparative effectiveness study that evaluated two different… View more

Digital Health

Heart Failure
ESC HF 25: The VELOCITY Study
Author(s): Stephen J Greene Added: 3 days ago
ESC HF 25 - VELOCITY shows bypassing an initiation dose of 2.5mg, and and beginning with 5mg vericiguat safe and tolerable in 9/10 patients with heart failure with ejection fraction <45%.Prof Stephen Greene (Duke Clinical Research Institute, US) discusses the findings from VELOCITY (NCT06195930; Bayer), a phase 2b open-label clinical study evaluating the tolerability and safety of an… View more

Heart Failure
View from the Thoraxcenter: EuroPCR 25 Late-breaking Preview
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 2 weeks ago
Step into the forefront of interventional cardiology with distinguished experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) as they provide a comprehensive overview of EuroPCR 2025's most anticipated late-breaking trials.Optimize your conference preparation through this essential preview, where expert commentary outlines the clinical significance of this… View more

Intervention